Search Results
Jun 08, 2026, 09:00 ET Clarivate Announces Simon Webster as President of Intellectual Property Segment
statements. These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk Factors in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission ("SEC"). There can be no assurance that future developments affecting
More news about: Clarivate Plc
Jun 08, 2026, 08:50 ET Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
https://rosenlegal.com/submit-form/?case_id=56548 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Jun 08, 2026, 08:40 ET WiMi Explores Multi-Dimensional Pooling Optimization Technology under the Variational Quantum Algorithm Framework
characteristics of quantum states combined with preset pooling strategies to selectively extract key feature information from quantum states in probabilistic form.As the core driver of the entire optimization scheme, VQA constructs a hybrid optimization framework by integrating quantum computing and classical
More news about: WiMi Hologram Cloud Inc.
Jun 08, 2026, 08:37 ET Metropolitan Dermatology Introduces Nevisense® Technology for Advanced Melanoma Detection
be seen visually. This advanced technology enhances clinical decision-making and supports earlier, more accurate detection of melanoma—the deadliest form of skin cancer."Early detection is critical when it comes to melanoma," said Dr. Alex Doctoroff, CEO and Medical Director, at Metropolitan Dermatology.
More news about: Metropolitan Dermatology
Jun 08, 2026, 08:31 ET MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
described in MetaVia's filings with the Securities and Exchange Commission, including MetaVia's most recent Annual Report on Form 10-K. Forward-looking statements speak only as of the date when made. MetaVia does not assume any obligation to publicly update or revise
More news about: MetaVia Inc.
Jun 08, 2026, 08:30 ET Caris Life Sciences Announces Share Repurchase Program
risks, uncertainties; and other factors described in the section titled "Risk Factors" and elsewhere in our Annual Report on Form 10-K filed on March 3, 2026, our Quarterly Report on Form 10-Q filed on May 8, 2026, and in our other filings we make with the SEC from time to time. We undertake no obligation
More news about: Caris Life Sciences
Jun 08, 2026, 08:30 ET Eco Wave Power Explores AI-Powered Wave Energy Infrastructure and WaveGPT Development with Florida Atlantic University and University of Michigan
[email protected]: Information available on or through the websites mentioned herein does not form part of this press release.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning
More news about: Eco Wave Power Global AB (publ)
Jun 08, 2026, 08:30 ET BJ's Restaurant & Brewhouse Serves Up a Sweet Salute to the Red, White & Blue with New Stars & Stripes Pizookie®
earned over 270 medals and awards for brewing excellence. Together with the Stars & Stripes Pizookie®, these three limited-time offerings form BJ's summer hat trick—a winning combination that scores big with guests looking to celebrate the season.For more information on the Stars &
More news about: BJ's Restaurants, Inc.
Jun 08, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.54 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
statements are subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings
More news about: Bitmine Immersion Technologies, Inc.
Jun 08, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.54 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
statements are subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings
More news about: Bitmine Immersion Technologies, Inc.
Jun 08, 2026, 08:30 ET Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities
in the Company's periodic reports filed with the Securities and Exchange Commission, including without limitation the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2026. Neurocrine Biosciences disclaims any obligation to update the statements contained in this press release
More news about: Neurocrine Biosciences, Inc.
Jun 08, 2026, 08:17 ET Simulations Plus (SLP) Securities Investigation: Johnson Fistel Reviews Revenue Guidance Cut, $77.2M Impairment Charge, and Auditor Dispute
accounting firm. In the Company's Form 8-K, Simulations Plus stated that certain matters relating to segment reporting, reporting-unit determinations, and internal control over financial reporting could not be finalized in time for the Company's Quarterly Report on Form 10-Q.Grant Thornton later
More news about: Johnson Fistel, PLLP
Jun 08, 2026, 08:10 ET Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
Additional risks relating to Colospan's product and its strategy are detailed in a report on Form 6-K filed by Galmed with the SEC on June 8, 2026 and risks associated with Galmed are detailed in Galmed's Annual Report on Form 20-F for the year ended December 31, 2025, filed with the SEC on March 31, 2026 under
More news about: Galmed Pharmaceuticals Ltd.
Jun 08, 2026, 08:04 ET TransCode Therapeutics to Host R&D Webcast on June 18, 2026
differ from those contained in or implied by the forward-looking statements, see the section entitled "Risk Factors" in TransCode's Annual Report on Form 10-K for the year ended December 31, 2025, as well as discussions of potential risks, uncertainties and other important factors in any subsequent TransCode
More news about: TransCode Therapeutics, Inc.
Jun 08, 2026, 08:02 ET Deloitte and Ironclad Form Strategic Alliance to Expand Agentic Contract Lifecycle Management Capabilities
multimedia:https://www.prnewswire.com/news-releases/deloitte-and-ironclad-form-strategic-alliance-to-expand-agentic-contract-lifecycle-management-capabilities-302792332.htmlSOURCE
More news about: Deloitte
Jun 08, 2026, 08:02 ET EPAM and TGS Announce Strategic Collaboration to Accelerate AI Adoption at Scale in Energy Sector
implied include general economic conditions, the risk factors discussed in the Company's most recent Annual Report on Form 10-K and the factors discussed in the Company's Quarterly Reports on Form 10-Q, particularly under the headings "Management's Discussion and Analysis of Financial Condition and Results
More news about: EPAM Systems, Inc.
Jun 08, 2026, 08:00 ET Were you notified that your Personal Information may have been compromised in a Data Exposure involving Lemonade Insurance Agency's insurance quotation platform? You may be eligible for benefits from a class action settlement.
automatically receive three years of Credit Monitoring and Insurance Services ("CMIS").How do I get a Settlement Payment? You must file a Claim Form online at
More news about: Kroll Settlement Administration LLC
Jun 08, 2026, 08:00 ET Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
disclosures made by the Company in its reports filed with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as revised or supplemented by its Quarterly Reports on Form 10-Q and other documents filed with the SEC. If one or more of these risks or uncertainties materialize,
More news about: Decoy Therapeutics, Inc
Jun 08, 2026, 08:00 ET CleanCore Solutions (ZONE) Appoints Tyler Hassen as CEO to Lead AI Infrastructure Buildout
U.S. Securities and Exchange Commission ("SEC"), including the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information,
More news about: CleanCore Solutions (NYSE AMERICAN: ZONE)
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange
More news about: AbbVie
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange
More news about: AbbVie
Jun 08, 2026, 07:30 ET ENHANCED GAMES SUCCESS DRIVING SIGNIFICANT GROWTH FOR "LIVE ENHANCED" CONSUMER PLATFORM
Company's filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" section of the Company's Registration Statement on Form S-4 (as amended) and any subsequent filings, available at www.sec.gov and on the Company's investor
More news about: Enhanced
Jun 08, 2026, 07:30 ET Full Circle Lithium's FCL-X™ Extinguishes Lithium Battery Fires at Fort McMurray Oil Industry Demonstration
Demonstration That Left No DoubtDuring the live demonstration, FCL ignited lithium-ion batteries representing multiple chemistries and form factors commonly deployed across oilsands operations and backup power configuration battery arrays. In each case, FCL-X™ achieved rapid,
More news about: Full Circle Lithium Inc
Jun 08, 2026, 07:30 ET Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
combined with previous and ongoing work in Dr. Lehrer's laboratory that has demonstrated platform compatibility of the key Bundibugyo virus antigen, will form the basis of an application to CEPI enabling rapid development of a protein-based thermostable subunit vaccine for BDBV.
More news about: SOLIGENIX, INC.